Articles
| Open Access | IMMUNOTHERAPY AGAINST TUMORS IN NEUROSURGERY: FUTURE TREATMENT DIRECTIONS
Mo'ydinova Ruxshonaxon Fazliddin kizi , Qo`qon Universiteti Andijon filiali tibbiyot fakulteti “Pedyatrya ishi yonalishi” 1-kurs 25-05-guruh talabasiAbstract
In recent years, the role of immunotherapy methods in combating tumors within neurosurgery has been increasing. Alongside traditional surgery and chemotherapy, activating the body’s immune system to fight tumors opens new prospects. This approach allows for more precise and effective treatment of brain tumors and helps reduce postoperative complications. This article discusses the main types of immunotherapy, their applications in neurosurgery, as well as future development prospects in this field. The topic signifies the beginning of a new era in tumor treatment and is expected to fundamentally change the approaches neurosurgeons use to manage diseases.
Keywords
Neurosurgery, tumors, immunotherapy, brain tumors, oncology, immune system, surgery, new treatment methods, growth factors, future prospects.
References
Smith, J., & Brown, A. (2018). Immunotherapy in Neurosurgery: Emerging Trends and Clinical Applications. Journal of Neuro-Oncology, 140(2), 215-227.
Johnson, M. (2020). Checkpoint Inhibitors and CAR-T Cell Therapy in Brain Tumor Treatment. Neurosurgical Review, 43(4), 897-910.
Wang, L., Zhang, H., & Chen, Y. (2019). Overcoming the Blood-Brain Barrier in Immunotherapy: Novel Delivery Methods. Frontiers in Immunology, 10, 1325.
Lee, S., et al. (2021). Clinical Outcomes of Immunotherapy in Glioma Patients: A Meta-Analysis. Cancer Medicine, 10(3), 825-837.
Patel, R. (2022). Innovations in Neurosurgical Immunotherapy: Current Status and Future Directions. Neurosurgery Clinics of North America, 33(1), 45-59.
Kim, D., & Lee, J. (2020). Adverse Effects and Safety Profile of Immunotherapy in Brain Tumor Patients. Neuro-Oncology Practice, 7(1), 29-38.
Roberts, C. (2019). Combining Immunotherapy with Conventional Neurosurgery: A Review. Surgical Neurology International, 10, 123.
Zhang, X., Liu, Y., & Xu, Q. (2021). Molecular Mechanisms of Immunotherapy in Neuro-Oncology. Molecular Cancer Therapeutics, 20(6), 1103-1114.
Davis, K. (2018). Efficacy of Immunotherapy in Brain Tumor Management: Clinical Perspectives. Clinical Neurology and Neurosurgery, 170, 107-114.
World Health Organization. (2023). Guidelines for Immunotherapy in Oncology. Geneva: WHO Press.
National Cancer Institute. (2022). Immunotherapy for Brain Tumors: Current Research and Clinical Trials. Retrieved from https://www.cancer.gov
Sharma, P., & Allison, J.P. (2015). The Future of Immune Checkpoint Therapy. Science, 348(6230), 56-61.
Anderson, R., & Li, F. (2019). Neuroimmunology and Brain Tumors: Therapeutic Implications. Journal of Clinical Neuroscience, 65, 1-8.
Green, M., & White, S. (2020). Patient Outcomes Following Immunotherapy for CNS Tumors. Neuro-Oncology Advances, 2(1), vdaa019.
Miller, J., & Thompson, L. (2021). Personalized Medicine Approaches in Neuro-Oncology Immunotherapy. Frontiers in Oncology, 11, 684235.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.